Skip to main content
. 2015 Sep 15;6(32):33926–33934. doi: 10.18632/oncotarget.5271

Figure 1. Nasopharyngeal images of recurrent nasopharyngeal carcinoma patients.

Figure 1

Patients with IMRT alone: A1. Before re-irradiation of patient A, A2. End of re-irradiation of patient A, B1. End of re-irradiation of patient B, B2. 2 years after re-irradiation of patient B; Patients with Endostar® + IMRT, C1. End of re-irradiation of patient C, C2. 1 month after re-irradiation of patient C, D1. End of re-irradiation of patient D, D2. 18 months after re-irradiation of patient D. IMRT, Intensity-modulated radiotherapy.